1Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada. 2Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand.
Crit Care Med. 2016 Nov;44(11):1966-1973. doi: 10.1097/CCM.0000000000001870.
Visceral and subcutaneous adipose tissue may contribute differentially to the septic inflammatory response. Accordingly, we tested the hypothesis that the ratio of visceral to subcutaneous adipose tissue is associated with altered sepsis outcome.
A retrospective analysis from a cohort of sepsis patients admitted between 2004 and 2009.
A mixed medical-surgical ICU at St. Paul's Hospital in Vancouver, Canada.
Patients older than 16 years old who had sepsis and underwent abdominal CT scan (n = 257) for clinical reasons.
None.
We measured the visceral adipose tissue and subcutaneous adipose tissue areas and calculated the visceral adipose tissue-to-subcutaneous adipose tissue ratio. Visceral adipose tissue/subcutaneous adipose tissue was not correlated with body mass index (r = -0.015, p = NS) and therefore provides additional unique information independent of body mass index. Sepsis patients with higher visceral adipose tissue/subcutaneous adipose tissue had greater 90-day mortality than patients with lower visceral adipose tissue/subcutaneous adipose tissue (log-rank test, linear-by linear association p < 0.005). After adjustment for significant covariates using Cox regression, increased visceral adipose tissue/subcutaneous adipose tissue quartile was significantly associated with increased 90-day mortality with hazard ratios of 2.01 (95% CI, 1.01-3.99) for the third visceral adipose tissue/subcutaneous adipose tissue quartile compared with the first quartile and 2.32 (95% CI, 1.15-4.69) for the highest visceral adipose tissue/subcutaneous adipose tissue quartile when compared with the first quartile. Increased mortality for patients with higher visceral adipose tissue/subcutaneous adipose tissue was found for both patients with body mass index less than 25 kg/m (p = 0.004) and for body mass index greater than or equal to 25 kg/m (p = 0.023). Furthermore, we found significantly greater need for mechanical ventilation, renal replacement therapy, and ICU stay in patients in the highest visceral adipose tissue/subcutaneous adipose tissue quartile. The ratio of proinflammatory (interleukin-8) to anti-inflammatory (interleukin-10) plasma cytokine levels was greater in patients with higher visceral adipose tissue/subcutaneous adipose tissue than in those with lower visceral adipose tissue/subcutaneous adipose tissue (p = 0.043).
Visceral obesity, defined by a high visceral adipose tissue-to-subcutaneous adipose tissue ratio, contributes to adverse outcome in sepsis patients perhaps because of a greater pro- versus anti-inflammatory response.
内脏和皮下脂肪组织可能对脓毒症炎症反应有不同的影响。因此,我们假设内脏脂肪组织与皮下脂肪组织的比例与改变脓毒症的预后有关。
对 2004 年至 2009 年间入住温哥华圣保罗医院混合内科-外科重症监护病房的脓毒症患者进行的回顾性分析。
加拿大温哥华圣保罗医院的混合内科-外科重症监护病房。
年龄大于 16 岁,因临床原因接受腹部 CT 扫描的脓毒症患者(n=257)。
无。
我们测量了内脏脂肪组织和皮下脂肪组织的面积,并计算了内脏脂肪组织与皮下脂肪组织的比值。内脏脂肪组织/皮下脂肪组织与体重指数不相关(r=0.015,p=NS),因此提供了独立于体重指数的额外独特信息。内脏脂肪组织/皮下脂肪组织较高的脓毒症患者 90 天死亡率高于内脏脂肪组织/皮下脂肪组织较低的患者(对数秩检验,线性-线性关联 p<0.005)。使用 Cox 回归对显著协变量进行调整后,增加的内脏脂肪组织/皮下脂肪组织四分位间距与 90 天死亡率增加显著相关,与第一四分位间距相比,第三四分位间距的危险比为 2.01(95%CI,1.01-3.99),与第一四分位间距相比,最高四分位间距的危险比为 2.32(95%CI,1.15-4.69)。对于 BMI<25kg/m 的患者(p=0.004)和 BMI≥25kg/m 的患者(p=0.023),内脏脂肪组织/皮下脂肪组织较高的患者死亡率均显著增加。在最高内脏脂肪组织/皮下脂肪组织四分位间距的患者中,需要机械通气、肾脏替代治疗和 ICU 住院的患者明显更多。与内脏脂肪组织/皮下脂肪组织较低的患者相比,内脏脂肪组织/皮下脂肪组织较高的患者的促炎(白细胞介素-8)与抗炎(白细胞介素-10)血浆细胞因子水平的比值更高(p=0.043)。
内脏肥胖,定义为内脏脂肪组织与皮下脂肪组织的比例较高,可能是由于促炎与抗炎反应的比例更高,导致脓毒症患者的预后不良。